<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">19926697</PMID>
        <DateCompleted>
            <Year>2009</Year>
            <Month>11</Month>
            <Day>30</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1756-1833</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>339</Volume>
                    <PubDate>
                        <Year>2009</Year>
                        <Month>Nov</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMJ (Clinical research ed.)</Title>
                <ISOAbbreviation>BMJ</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment.</ArticleTitle>
            <Pagination>
                <MedlinePgn>b4571</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.b4571</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">bmj.b4571</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To estimate the potential economic impact of pandemic influenza, associated behavioural responses, school closures, and vaccination on the United Kingdom.</AbstractText>
                <AbstractText Label="DESIGN" NlmCategory="METHODS">A computable general equilibrium model of the UK economy was specified for various combinations of mortality and morbidity from pandemic influenza, vaccine efficacy, school closures, and prophylactic absenteeism using published data.</AbstractText>
                <AbstractText Label="SETTING" NlmCategory="METHODS">The 2004 UK economy (the most up to date available with suitable economic data).</AbstractText>
                <AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The economic impact of various scenarios with different pandemic severity, vaccination, school closure, and prophylactic absenteeism specified in terms of gross domestic product, output from different economic sectors, and equivalent variation.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The costs related to illness alone ranged between 0.5% and 1.0% of gross domestic product ( pound8.4bn to pound16.8bn) for low fatality scenarios, 3.3% and 4.3% ( pound55.5bn to pound72.3bn) for high fatality scenarios, and larger still for an extreme pandemic. School closure increases the economic impact, particularly for mild pandemics. If widespread behavioural change takes place and there is large scale prophylactic absence from work, the economic impact would be notably increased with few health benefits. Vaccination with a pre-pandemic vaccine could save 0.13% to 2.3% of gross domestic product ( pound2.2bn to pound38.6bn); a single dose of a matched vaccine could save 0.3% to 4.3% ( pound5.0bn to pound72.3bn); and two doses of a matched vaccine could limit the overall economic impact to about 1% of gross domestic product for all disease scenarios.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Balancing school closure against &quot;business as usual&quot; and obtaining sufficient stocks of effective vaccine are more important factors in determining the economic impact of an influenza pandemic than is the disease itself. Prophylactic absence from work in response to fear of infection can add considerably to the economic impact.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>Richard D</ForeName>
                    <Initials>RD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Policy Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7HT. richard.smith@lshtm.ac.uk</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Keogh-Brown</LastName>
                    <ForeName>Marcus R</ForeName>
                    <Initials>MR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barnett</LastName>
                    <ForeName>Tony</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tait</LastName>
                    <ForeName>Joyce</ForeName>
                    <Initials>J</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2009</Year>
                <Month>11</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMJ</MedlineTA>
            <NlmUniqueID>8900488</NlmUniqueID>
            <ISSNLinking>0959-8138</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>BMJ. 2009;339:b4888</RefSource>
                <PMID Version="1">19926698</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000041" MajorTopicYN="N">Absenteeism</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003132" MajorTopicYN="N">Commerce</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004467" MajorTopicYN="N">Economics</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
                <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018803" MajorTopicYN="N">Models, Economic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012572" MajorTopicYN="N">School Health Services</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006113" MajorTopicYN="N">United Kingdom</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
                <QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2009</Year>
                <Month>11</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2009</Year>
                <Month>11</Month>
                <Day>21</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2009</Year>
                <Month>12</Month>
                <Day>16</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">19926697</ArticleId>
            <ArticleId IdType="pmc">PMC2779854</ArticleId>
            <ArticleId IdType="doi">10.1136/bmj.b4571</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12781535</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Microbiol. 2003 Dec;1(3):209-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15035025</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2005 Oct 29;331(7523):975-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16246859</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2005 Nov 16;23(46-47):5365-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16029916</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2006 Jul 27;442(7101):448-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16642006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Psychiatry Clin Neurosci. 2006 Aug;60(4):397-403</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16884438</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2006 Nov;24(11):1377-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17093488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Infect Dis. 2007 Sep;13(9):1307-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18252100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2008;3(2):e1665</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18301743</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2008 Apr 10;452(7188):750-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18401408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Public Health. 2008;8:135</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18435855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Policy. 2008 Oct;88(1):110-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18436332</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2009;338:b1791</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19406879</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2009 Aug;9(8):473-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19628172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2009 Jul 30;460(7255):562</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19641566</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Econ. 2010 Nov;19(11):1345-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19816886</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Health Econ. 2010 Dec;11(6):543-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19997956</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
